205 related articles for article (PubMed ID: 18044409)
1. [Treatment for Helicobacter pylori: current criteria].
Vaira D; Zullo A; Ricci C; Gigliotti F; Morini S
Recenti Prog Med; 2007 Nov; 98(11):574-82; quiz 602. PubMed ID: 18044409
[TBL] [Abstract][Full Text] [Related]
2. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R
Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
[TBL] [Abstract][Full Text] [Related]
3. Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
Wong WM; Gu Q; Chu KM; Yee YK; Fung FM; Tong TS; Chan AO; Lai KC; Chan CK; Wong BC
Aliment Pharmacol Ther; 2006 Feb; 23(3):421-7. PubMed ID: 16423001
[TBL] [Abstract][Full Text] [Related]
4. Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study.
Zullo A; De Francesco V; Scaccianoce G; Hassan C; Panarese A; Piglionica D; Panella C; Morini S; Ierardi E
Dig Liver Dis; 2005 Jul; 37(7):496-500. PubMed ID: 15975536
[TBL] [Abstract][Full Text] [Related]
5. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
[TBL] [Abstract][Full Text] [Related]
6. Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
Ueki N; Miyake K; Kusunoki M; Shindo T; Kawagoe T; Futagami S; Tsukui T; Inagaki H; Sakamoto C
Helicobacter; 2009 Apr; 14(2):91-9. PubMed ID: 19298336
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Helicobacter pylori infection.
Cavallaro LG; Egan B; O'Morain C; Di Mario F
Helicobacter; 2006 Oct; 11 Suppl 1():36-9. PubMed ID: 16925610
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Helicobacter pylori infection.
Egan BJ; Marzio L; O'Connor H; O'Morain C
Helicobacter; 2008 Oct; 13 Suppl 1():35-40. PubMed ID: 18783520
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Helicobacter pylori.
Egan BJ; Katicic M; O'Connor HJ; O'Morain CA
Helicobacter; 2007 Oct; 12 Suppl 1():31-7. PubMed ID: 17727458
[TBL] [Abstract][Full Text] [Related]
10. Rifabutin based triple therapy for eradication of H. pylori primary and secondary resistant to tinidazole and clarithromycin.
Toracchio S; Capodicasa S; Soraja DB; Cellini L; Marzio L
Dig Liver Dis; 2005 Jan; 37(1):33-8. PubMed ID: 15702857
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori infection: sequential therapy followed by levofloxacin-containing triple therapy provides a good cumulative eradication rate.
Manfredi M; Bizzarri B; de'Angelis GL
Helicobacter; 2012 Aug; 17(4):246-53. PubMed ID: 22759323
[TBL] [Abstract][Full Text] [Related]
12. Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.
Tong JL; Ran ZH; Shen J; Xiao SD
J Clin Pharm Ther; 2009 Feb; 34(1):41-53. PubMed ID: 19125902
[TBL] [Abstract][Full Text] [Related]
13. [Double blind randomized multicentre study of a seven-day eradication regime of Helicobacter pylori by omeprazole, clarithromycin and ornidazole vs. omeprazole, clarithromycin and metronidazole].
Díte P; Kunovská M; Pulgretová D; Woznica V; Petrtýl J; Hůlek P; Pásková J; Dostalík Z; Novotný I; Procházka V; Hegyi P; Zelenková J; Samek M; Králová Z; Vyhnálek P; Matejovic F; Weinberg J; Kyzeková J
Vnitr Lek; 2002 Oct; 48(10):976-80. PubMed ID: 16737149
[TBL] [Abstract][Full Text] [Related]
14. Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates.
Romano M; Iovene MR; Russo MI; Rocco A; Salerno R; Cozzolino D; Pilloni AP; Tufano MA; Vaira D; Nardone G
J Clin Pathol; 2008 Oct; 61(10):1112-5. PubMed ID: 18755715
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies.
Fischbach LA; van Zanten S; Dickason J
Aliment Pharmacol Ther; 2004 Nov; 20(10):1071-82. PubMed ID: 15569109
[TBL] [Abstract][Full Text] [Related]
16. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
[TBL] [Abstract][Full Text] [Related]
17. Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy.
Cheng HC; Chang WL; Chen WY; Yang HB; Wu JJ; Sheu BS
Helicobacter; 2007 Aug; 12(4):359-63. PubMed ID: 17669110
[TBL] [Abstract][Full Text] [Related]
18. How to proceed in Helicobacter pylori-positive chronic gastritis refractory to first- and second-line eradication therapy.
Vaira D; Ricci C; Lanzini A; Perna F; Romano A; Corinaldesi R
Dig Dis; 2007; 25(3):203-5. PubMed ID: 17827940
[TBL] [Abstract][Full Text] [Related]
19. Pylera for the eradication of Helicobacter pylori infection.
Saleem A; Qasim A; O'Connor HJ; O'Morain CA
Expert Rev Anti Infect Ther; 2009 Sep; 7(7):793-9. PubMed ID: 19735221
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori diagnosis and management.
Vilaichone RK; Mahachai V; Graham DY
Gastroenterol Clin North Am; 2006 Jun; 35(2):229-47. PubMed ID: 16880064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
